MorphoSys AG (NAS:MOR)
$ 18.2 0 (0%) Market Cap: 2.74 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 51.84 GF Score: 63/100

MorphoSys AG at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 07:50PM GMT
Release Date Price: $28.51 (+0.92%)
James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon, and good evening. I'm James Gordon, JPMorgan European pharma biotech analyst. And today, it gives me great pleasure to introduce Jean-Paul Kress, CEO of MorphoSys, for this Presentation at the JPMorgan Healthcare Conference.

So today, we'll have a 20-minute presentation from Jean-Paul. And then we'll have 20-minutes for questions. And then we'll also have our Chief R&D Officer, Malte Peters; and COO, Roland Wandeler. You can immediately start registering your questions. And the way to do this is with the Q&A function that's associated with this presentation on the conference website, and then I'll be reading your questions from there.

And with that said, I'd like to welcome Jean-Paul to the conference and look forward to the presentation.

Jean;Paul Kress
MorphoSys AG - Chairman of Management Board, MD & CEO

Thank you, James. First, Happy New Year to all of you. I hope you're all keeping safe and healthy in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot